Your browser doesn't support javascript.
loading
Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.
Sakaue, Takahiko; Koga, Hironori; Iwamoto, Hideki; Nakamura, Toru; Ikezono, Yu; Abe, Mitsuhiko; Wada, Fumitaka; Masuda, Atsutaka; Tanaka, Toshimitsu; Fukahori, Masaru; Ushijima, Tomoyuki; Mihara, Yuutarou; Naitou, Yoshiki; Okabe, Yoshinobu; Kakuma, Tatsuyuki; Ohta, Keisuke; Nakamura, Kei-Ichiro; Torimura, Takuji.
  • Sakaue T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Koga H; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan. hirokoga@med.kurume-u.ac.jp.
  • Nakamura T; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan. hirokoga@med.kurume-u.ac.jp.
  • Ikezono Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Abe M; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Wada F; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Masuda A; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Tanaka T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Fukahori M; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Ushijima T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Mihara Y; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Naitou Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Okabe Y; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Kakuma T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Ohta K; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
  • Nakamura KI; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Torimura T; Liver Cancer Research Division, Kurume University Research Center for Innovative Cancer Therapy, Kurume, Japan.
Med Mol Morphol ; 52(4): 198-208, 2019 Dec.
Article en En | MEDLINE | ID: mdl-30805710
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ascitis / Biomarcadores de Tumor / Exosomas / Antígeno AC133 Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ascitis / Biomarcadores de Tumor / Exosomas / Antígeno AC133 Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article